A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma

Journal of Cosmetic Dermatology

Volumn 11, Issue 1, 2012, Pages 65-71

  Sobhi, Rehab Mohamed ^a   Sobhi, Ahmed Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Glycolic acid 70 ; Iontophoresis; Melasma; Nanosome vitamin C mesosolution

Indexed keywords

ASCORBIC ACID; GLYCOLIC ACID; NANOSOME VITAMIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EGYPT; FEMALE; HUMAN; IONTOPHORESIS; MEDICAL PHOTOGRAPHY; NANOSOME VITAMIN C IONTOPHORESIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; CHEMEXFOLIATION; FEMALE; GLYCOLATES; HUMANS; IONTOPHORESIS; KERATOLYTIC AGENTS; LIPOSOMES; MELANOSIS; MIDDLE AGED; NANOPARTICLES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 84857484475     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2011.00599.x     Document Type: Article

References (22)

1. Sarkar R, Kaur C, Bhalla M, Kanwar A. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 2002; 28: 828-32.
2. Khunger N, Sarkar R, Jain RK. Tretinoin peel versus glycolic acid peels in the treatment of melasma in dark Skinned Patients. Dermatol Surg 2004; 30: 756-60.
3. Sachovela S. Comparative efficacy of 10-20% trichloroacetic acid and 35-70% glycolic acid peel in 60 cases of melasma, freckles, lentigines and postinflammatory hyperpigmentation. J Pak Assoc Dermatol 2006; 16: 74-8.
4. Ros JR, Rodriguez-Lopes JN, Garcia-Canovas F. Effect of L-ascorbic acid on the monophelase activity of tyrosinase. Biochem J 1993; 295: 309-12.
5. Sherdin U, Filbry A, Scholermann A, Rippke F. Skin lightening products for patients with facial melasma. Eur Dermatol 2010; 5: 68-73.
6. Humbert PG, Haftek M, Creidi P et al. Topical ascorbic acid in photoaged skin. Clinical topographical and ultrastructural evaluations: double blinded study vs placebo. Exp Dermatol 2003; 12: 237.
7. Huh CH, Seo K, Park JY et al. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology 2003; 206: 316-20.
8. Kimbrough-Green CK, Griffiths CEM, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in Black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-33.
9. Lawrence N. Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol 1997; 36: 589-93.
10. Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol 2002; 138: 1578-82.
11. Lim JTE, Tham SN. Glicolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 1997; 23: 177-9.
12. Rendon M, Cardona LM, Bussear EW et al. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study. Cutis 2008; 82: 372-8.
13. Sezer E, Erbil H, Kurumlu Z et al. A comparative study of focal medium-depth chemical peel versus cryosurgery for the treatment of solar lentigo. Eur J Dermatol Jan-Feb, 2007; 17: 26-9.
14. Kameyama K, Sakai C, Kondoh S et al. Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro And in vivo. J Am Acad Dematol 1996; 34: 29-33.
15. Dreher F, Maibach H. Protective effects of topical antioxidants in humans. Curr Probl Dermatol 2001; 29: 157-64.
16. Darr D, Combs S, Dunston S et al. Topical vitamin C protects porcine skin from ultraviolet radiation induced damage. Br J Dermatol 1992; 127: 247-51.
17. Catani MV, Rossi A, Costanzo A et al. Induction of gene expression via activator protein 1 in ascorbate protection against UV-induced damage. Biochem J 2001; 15: 77-85.
18. Espinal-Perez LE, Moncado B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol 2004; 43: 604-7.
19. Lee SH, Choi EH, Feingold KR et al. Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment. J Invest Dermatol 1998; 111: 39-43.
20. Green PG, Flanagan M, Shroot B, Guy RH. Iontophoretic drug delivery. In: Walkers KA, Hadgraft J eds. Pharmaceutical Skin Penetration Enhancement. New York: Dekker; 1993: 311-33.
21. Chien YW, Siddiqui O, Shi WM et al. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J Pharm Sci 1989; 78: 376-84.
22. Grimmes S. Pathways of ionic flow through human skin in vivo. Acta Derm Venereol (Stockh) 1984; 64: 93-8.